Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models

키워드

참고문헌 (67)

1. El-Serag HB, "Hepatocellular carcinoma : epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
2. Sakurai T, "Molecular link between liver fibrosis and hepatocellular carcinoma", Liver Cancer, 2, pp.365~366 (2013)
3. 권오상, "염증과 간섬유화, 그리고 간세포암", 대한소화기학회지, 66(6), pp.320~324 (2015), 대한소화기학회
4. Filozof C, "Non-alcoholic steatohepatitis : limited available treatment options but promising drugs in development and recent progress towards a regulatory approval pathway", Drugs, 75, pp.1373~1392 (2015)
5. Llovet JM, "Immunotherapies for hepatocellular carcinoma", Nat Rev Clin Oncol, 19, pp.151~172 (2022)
6. Luo XY, "Advances in drug development for hepatocellular carcinoma : clinical trials and potential therapeutic targets", J Exp Clin Cancer Res, 40, pp.172~ (2021)
7. Kammerer S, "Three-dimensional liver culture systems to maintain primary hepatic properties for toxicological analysis in vitro", Int J Mol Sci, 22, pp.10214~ (2021)
8. Song Y, "Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids", Sci Rep, 6, pp.36750~ (2016)
9. Barry AE, "Hepatic stellate cells and hepatocarcinogenesis", Front Cell Dev Biol, 8, pp.709~ (2020)
10. Tsuchida T, "Mechanisms of hepatic stellate cell activation", Nat Rev Gastroenterol Hepatol, 14, pp.397~411 (2017)
11. Ali E, "Activated hepatic stellate cells in hepatocellular carcinoma : their role as a potential target for future therapies", Int J Mol Sci, 23, pp.15292~ (2022)
12. Thompson AI, "Hepatic stellate cells : central modulators of hepatic carcinogenesis", BMC Gastroenterol, 15, pp.63~ (2015)
13. Myojin Y, "Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production", Gastroenterology, 160, pp.1741~1754 (2021)
14. Lee SY, "Inhibition of 11betahydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH", Cell Death Dis, 13, pp.1011~ (2022)
15. Kyu Jin Choi, "Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage", Experimental and Molecular Medicine, 52, pp.1~12 (2020), 생화학분자생물학회[DOI]
16. Song Y, "Identification of radiation-induced EndMT inhibitors through cell-based phenomic screening", FEBS Open Bio, 9, pp.82~91 (2019)
17. Song S, "Foxm1 is a critical driver of TGF-beta-induced EndMT in endothelial cells through Smad2", 3 and binds to the Snail promoter, 2019, pp.234, 9052~9064
18. Mahmoud MM, "Shear stress induces endothelial-to-mesenchymal transition via the transcription factor Snail", Sci Rep, 7, pp.3375~ (2017)
19. Kim SH, "GSK-3beta regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models", J Exp Clin Cancer Res, 38, pp.46~ (2019)
20. 이민지, "Expression of HYOU1 via Reciprocal Crosstalk between NSCLC Cells and HUVECs Control Cancer Progression and Chemoresistance in Tumor Spheroids", Molecules and Cells, 44(1), pp.50~62 (2021), 한국분자세포생물학회[DOI]
21. Tian Z, "Macrophages and hepatocellular carcinoma", Cell Biosci, 9, pp.79~ (2019)
22. Arvanitakis K, "Tumor-associated macrophages in hepatocellular carcinoma pathogenesis, prognosis and therapy", Cancers(Basel), 14, pp.226~ (2022)
23. Xiao P, "Neurotensin", IL-8pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells, 2018, pp.7, e1440166~
24. Yin Z, "Macrophages activating chemokine(C-X-C motif)ligand 8", miR-17 cluster modulate hepatocellular carcinoma cell growth and metastasis, 2017, pp.9, 2403~2411
25. Huang Y, "The role of tumor associated macrophages in hepatocellular carcinoma", J Cancer, 12, pp.1284~1294 (2021)
26. Dong P, "CD86(+)", CD206(+), Diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis, 2016, pp.17, 320~
27. Kubo N, "Cancer-associated fibroblasts in hepatocellular carcinoma", World J Gastroenterol, 22, pp.6841~6850 (2016)
28. Jia W, "The role of cancer-associated fibroblasts in hepatocellular carcinoma and the value of traditional chinese medicine treatment", Front Oncol, 11, pp.763519~ (2021)
29. Duran A, "p62", SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer, 2016, pp.30, 595~609
30. Zhao Z, "Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy", Cancer Manag Res, 11, pp.5737~5744 (2019)
31. Song Y, "Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma", J Exp Clin Cancer Res, 37, pp.109~ (2018)
32. Al Hrout A, "Modelling liver cancer microenvironment using a novel 3D culture system", Sci Rep, 12, pp.8003~ (2022)
33. Lee KH, "Recent advances in multicellular tumor spheroid generation for drug screening", Biosensors(Basel), 11, pp.445~ (2021)
34. Wang Q, "Generation of multicellular tumor spheroids with micro-well array for anticancer drug combination screening based on a valuable biomarker of hepatocellular carcinoma", Front Bioeng Biotechnol, 10, pp.1087656~ (2022)
35. Song Y, "Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model", Sci Rep, 11, pp.10931~ (2021)
36. Lim JTC, "Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment", Biomaterials, 284, pp.121527~ (2022)
37. Doumba PP, "Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells : study of their in vitro immunological interactions", BMC Gastroenterol, 13, pp.17~ (2013)
38. Kim S, "Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK", eIF2alpha, CHOP axis in hepatocellular carcinoma, pp.J Exp Clin Cancer Res, 2021[DOI]
39. Makridakis M, "Secretome proteomics for discovery of cancer biomarkers", J Proteomics, 73, pp.2291~2305 (2010)
40. Lee SY, "Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression", Cancer Lett, 551, pp.215960~ (2022)
41. Rawal P, "VEGFmediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma", Oncol Lett, 24, pp.315~ (2022)
42. Chen R, "Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential", Int J Clin Exp Pathol, 7, pp.2527~2535 (2014)
43. Kimlin LC, "In vitro three-dimensional(3D)models in cancer research : an update", Mol Carcinog, 52, pp.167~182 (2013)
44. Chen RX, "Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma", PLoS One, 9, pp.e88543~ (2014)
45. Lee SH, "Differential protein expression and novel biomarkers related to 5-FU resistance in a 3D colorectal adenocarcinoma model", Oncol Rep, 32, pp.1427~1434 (2014)
46. Song Y, "TGF-beta-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC", Oncotarget, 8, pp.21650~21662 (2017)
47. Hsiao YC, "Proteomic profiling of the cancer cell secretome : informing clinical research", Expert Rev Proteomics, 14, pp.737~756 (2017)
48. Jeon D, "Serum sorbitol dehydrogenase as a novel prognostic factor for hepatocellular carcinoma after surgical resection", Cancers(Basel), 13, pp.6143~ (2021)
49. Zanoni M, "Anticancer drug discovery using multicellular tumor spheroid models", Expert Opin Drug Discov, 14, pp.289~301 (2019)
50. Thanapirom K, "Optimization and validation of a novel three-dimensional co-culture system in decellularized human liver scaffold for the study of liver fibrosis and cancer", Cancers(Basel), 13, pp.4936~ (2021)
51. Lafnoune A, "Anti-cancer activity of buthus occitanus venom on hepatocellular carcinoma in 3D cell culture", Molecules, 27, pp.2219~ (2022)
52. Lafnoune A, "Anti-cancer effect of moroccan cobra naja haje venom and its fractions against hepatocellular carcinoma in 3D cell culture", Toxins(Basel), 13, pp.402~ (2021)
53. Liao W, "Therapeutic potential of CUDC-907(fimepinostat)for hepatocarcinoma treatment revealed by tumor spheroids-based drug screening", Front Pharmacol, 12, pp.658197~ (2021)
54. Hou J, "A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma", BMC Cancer, 17, pp.729~ (2017)
55. Song Y, "Inhibitors of Na(+)", K(+)ATPase exhibit antitumor effects on multicellular tumor spheroids of hepatocellular carcinoma, 2020, pp.10, 5318~
56. Rehman M, "High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation", JCI Insight, 4, pp.e123987~ (2019)
57. Arai K, "A novel high-throughput 3D screening system for EMT inhibitors : a pilot screening discovered the EMT inhibitory activity of CDK2 inhibitor SU9516", PLoS One, 11, pp.e0162394~ (2016)
58. Di Sanzo M, "Clinical applications of personalized medicine : a new paradigm and challenge", Curr Pharm Biotechnol, 18, pp.194~203 (2017)
59. Fong ELS, "Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer", Biomaterials, 159, pp.229~240 (2018)
60. Zhang L, "A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening", Cancer Lett, 500, pp.87~97 (2021)
61. Imamura Y, "Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer", Oncol Rep, 33, pp.1837~1843 (2015)
62. Kaur G, "Complex tumor spheroids, a tissue-mimicking tumor model, for drug discovery and precision medicine", SLAS Discov, 26, pp.1298~1314 (2021)
63. Kronemberger GS, "Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening", Artif Organs, 45, pp.548~558 (2021)
64. Hwang KS, "3D engineered tissue models for studying human-specific infectious viral diseases", Bioact Mater, 21, pp.576~594 (2023)
65. de Dios-Figueroa GT, "3D cell culture models in COVID-19 times : a review of 3D technologies to understand and accelerate therapeutic drug discovery", Biomedicines, 9, pp.602~ (2021)
66. Salgueiro L, "Generation of human lung organoid cultures from healthy and tumor tissue to study infectious diseases", J Virol, 96, pp.e0009822~ (2022)
67. Loy LM, "Variant hepatocellular carcinoma subtypes according to the 2019 WHO classification : an imagingfocused review", AJR Am J Roentgenol, 219, pp.212~223 (2022)

관련 논문AI추천